Skip to main content
Clinical Trials/NCT03170947
NCT03170947
Recruiting
Not Applicable

Effects of Insoles in Patients With Rheumatoid Arthritis Through Measurement of Quality of Life and Physical Activity: Randomized Controlled Trial.

University of Malaga1 site in 1 country96 target enrollmentStarted: January 21, 2022Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
96
Locations
1
Primary Endpoint
Change from Baseline Active graph (bracelet) at 3 months

Overview

Brief Summary

Deformity and foot pain is nearly omnipresent (90%) in rheumatoid arthritis (RA), due to the interaction between inflammation and abnormal biomechanical. These cause instability in the hindfoot, which cause deformity of the forefoot, and they cause more pressure on the plantar forefoot and more pain during daily activities. Non-pharmacological interventions (insole, footwear) have an important role, reducing pain and disability, increasing the effectiveness and improving daily activities.

Detailed Description

Randomized double-blind clinical trial. Two samples of patients will be taken: the control group, which will consist of patients with rheumatoid arthritis and standardized insoles, and other group, which will consist of patients with rheumatoid arthritis and insoles made with direct adaptation technique (TAD) and patients with rheumatoid arthritis and insoles made with an scanner (CAD-CAM). The variables that the investigators will measure are: age, sex, study level, current occupation, rheumatoid arthritis evolution time, quality of life and physical function, pain and health level and general function of the foot. The investigators will use: an accelerometer, and questionnaires: Foot and Ankle Ability Measures (FAAM), Manchester foot pain and disability index (MFPDI), Medical outcomes study short form-36 (SF-36) y Foot Function Index (FFI). This study will analyze patients in the Universities of Malaga and Salford for 6 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • More than 18 years of age
  • To meet the criteria of American College of Rheumatology
  • History of bilateral subtalar and/or ankle and/or talonavicular pain
  • Informed consent
  • Normal range of motions at the ankle, subtalar, and midtarsal joints.

Exclusion Criteria

  • Concomitant musculoskeletal disease
  • Central or peripheral nervous system disease
  • Endocrine disorders, especially diabetes mellitus with a level of insufficient foot sensitivity
  • Patients with a history of orthopedic foot surgery
  • Those currently using foot orthoses.
  • Patients with foot trauma in the last 6 months previous to the study
  • Vascular diseases affecting the foot, active synovitis and edema.
  • Normal daily walking aids will be not permitted.

Outcomes

Primary Outcomes

Change from Baseline Active graph (bracelet) at 3 months

Time Frame: one week, one month and three months

This outcome will be measured with an activity monitor, accelerometer

Secondary Outcomes

  • Change from Baseline quality of life at 3 months(one week, one month and three months)
  • Change from Baseline pain intensity at 3 months(one week, one month and three months)
  • Change from Baseline foot function 3 months(one week, one month and three months)
  • Change from Baseline physical activity at 3 months(one week, one month and three months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gabriel Gijon-Nogueron

Principal Investigator

University of Malaga

Study Sites (1)

Loading locations...

Similar Trials